Lacosamide Injection 200mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 200mg

Reference Brands: Vimpat (US/EU)

Injection contains the active constituent lacosamide. It is used to lower the number of fits (seizures) in epileptic patients. Epilepsy is a neurological disorder where nerve cells do not signal properly, which causes seizures.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: This medication is not recommended for children under four years of age. Do not stop taking this medicine without consulting your doctor, as it may increase your fits.

Lacosamide Injection — third party manufacturing & bulk supply

Lacosamide Injection 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lacosamide Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lacosamide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lacosamide Injection →

Back to Listing

Frequently Asked Questions

LACOSAMIDE INJECTION is listed as Injection in 200mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

LACOSAMIDE INJECTION is referenced against Vimpat (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.